Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR-130A-01 Contraceptive Patch Study in Women of Childbearing Potential
NCT06672016Phase 3Active, not recruiting
- Sponsor
- Mylan
- Start
- Jan 2025
- Primary completion
- May 2027
- Modality
- Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of MR-130A-01 in contraception, sponsored by Mylan. Started Jan 2025; status: active, not recruiting.
02
Drugs
MR-130A-01
03
Conditions
contraception
Beyond the preview
Go deeper on NCT06672016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06672016.